메뉴 건너뛰기




Volumn 32, Issue 32, 2014, Pages 3613-3618

Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS trial

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SPECIFIC SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MIDDLE AGED; OVERALL SURVIVAL; PARTIAL MASTECTOMY; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; ADJUVANT THERAPY; BREAST NEOPLASMS; CARCINOMA IN SITU; MAMMOGRAPHY; MASS SCREENING; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PROCEDURES; PROPORTIONAL HAZARDS MODEL; SEGMENTAL MASTECTOMY; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; SURVIVAL; SWEDEN; TIME; TUMOR RECURRENCE;

EID: 84911485938     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.56.2595     Document Type: Article
Times cited : (193)

References (20)
  • 1
    • 33746772725 scopus 로고    scopus 로고
    • SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast-Results of a randomised trial in a population offered mammography screening
    • Emdin SO, Granstrand B, Ringberg A, et al: SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast-Results of a randomised trial in a population offered mammography screening. Acta Oncol 45:536-543, 2006
    • (2006) Acta Oncol , vol.45 , pp. 536-543
    • Emdin, S.O.1    Granstrand, B.2    Ringberg, A.3
  • 2
    • 33746811910 scopus 로고    scopus 로고
    • Breastconserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group
    • Bijker N, Meijnen P, Peterse JL, et al: Breastconserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24:3381-3387, 2006
    • (2006) J Clin Oncol , vol.24 , pp. 3381-3387
    • Bijker, N.1    Meijnen, P.2    Peterse, J.L.3
  • 3
    • 0034883290 scopus 로고    scopus 로고
    • Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience
    • Fisher B, Land S, Mamounas E, et al: Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 28:400-418, 2001
    • (2001) Semin Oncol , vol.28 , pp. 400-418
    • Fisher, B.1    Land, S.2    Mamounas, E.3
  • 4
    • 0038304773 scopus 로고    scopus 로고
    • Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: Randomised controlled trial
    • Houghton J, George WD, Cuzick J, et al: Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: Randomised controlled trial. Lancet 362:95-102, 2003
    • (2003) Lancet , vol.362 , pp. 95-102
    • Houghton, J.1    George, W.D.2    Cuzick, J.3
  • 5
    • 78650717087 scopus 로고    scopus 로고
    • Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
    • Correa C, McGale P, Taylor C, et al: Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 41:162-177, 2010
    • (2010) J Natl Cancer Inst Monogr , vol.41 , pp. 162-177
    • Correa, C.1    McGale, P.2    Taylor, C.3
  • 6
    • 84877950429 scopus 로고    scopus 로고
    • A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ
    • Solin LJ, Gray R, Baehner FL, et al: A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ. J Natl Cancer Inst 105:701-710, 2013
    • (2013) J Natl Cancer Inst , vol.105 , pp. 701-710
    • Solin, L.J.1    Gray, R.2    Baehner, F.L.3
  • 7
    • 41649119767 scopus 로고    scopus 로고
    • Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast
    • Holmberg L, Garmo H, Granstrand B, et al: Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 26:1247-1252, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 1247-1252
    • Holmberg, L.1    Garmo, H.2    Granstrand, B.3
  • 8
    • 0023789243 scopus 로고
    • Standardization of the surgical technique in breastconserving treatment of mammary cancer
    • Aspegren K, Holmberg L, Adami HO: Standardization of the surgical technique in breastconserving treatment of mammary cancer. Br J Surg 75:807-810, 1988
    • (1988) Br J Surg , vol.75 , pp. 807-810
    • Aspegren, K.1    Holmberg, L.2    Adami, H.O.3
  • 9
    • 33846309700 scopus 로고    scopus 로고
    • Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast: Results from the Swedish randomised trial
    • Ringberg A, Nordgren H, Thorstensson S, et al: Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast: Results from the Swedish randomised trial. Eur J Cancer 43:291-298, 2007
    • (2007) Eur J Cancer , vol.43 , pp. 291-298
    • Ringberg, A.1    Nordgren, H.2    Thorstensson, S.3
  • 11
    • 0000120995 scopus 로고
    • A class of K-sample tests for comparing the cumulative incidence of a competing risk
    • Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
    • (1988) Ann Stat , vol.16 , pp. 1141-1154
    • Gray, R.J.1
  • 12
    • 0037102914 scopus 로고    scopus 로고
    • Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects
    • Royston P, Parmar MKB: Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 21:2175-2197, 2002
    • (2002) Stat Med , vol.21 , pp. 2175-2197
    • Royston, P.1    Parmar, M.K.B.2
  • 13
    • 79952845819 scopus 로고    scopus 로고
    • Longterm outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS
    • Wapnir IL, Dignam JJ, Fisher B, et al: Longterm outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103:478-488, 2011
    • (2011) J Natl Cancer Inst , vol.103 , pp. 478-488
    • Wapnir, I.L.1    Dignam, J.J.2    Fisher, B.3
  • 14
    • 78650700810 scopus 로고    scopus 로고
    • Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK/ANZ DCIS trial
    • Cuzick J, Sestak I, Pinder SE, et al: Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK/ANZ DCIS trial. Lancet Oncol 12:21-29, 2011
    • (2011) Lancet Oncol , vol.12 , pp. 21-29
    • Cuzick, J.1    Sestak, I.2    Pinder, S.E.3
  • 15
    • 84891512298 scopus 로고    scopus 로고
    • Breastconserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial
    • Donker M, Litière S, Werutsky G, et al: Breastconserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol 10:4054-4059, 2013
    • (2013) J Clin Oncol , vol.10 , pp. 4054-4059
    • Donker, M.1    Litière, S.2    Werutsky, G.3
  • 16
    • 84875225409 scopus 로고    scopus 로고
    • Mammography casting-type calcification and risk of local recurrence in DCIS: Analyses from a randomised study
    • Holmberg L, Wong YN, Tabár L, et al: Mammography casting-type calcification and risk of local recurrence in DCIS: Analyses from a randomised study. Br J Cancer 5:812-819, 2013
    • (2013) Br J Cancer , vol.5 , pp. 812-819
    • Holmberg, L.1    Wong, Y.N.2    Tabár, L.3
  • 17
    • 84876794573 scopus 로고    scopus 로고
    • High-grade histologic features of DCIS are associated with R5 rather than R3 calcifications in breast screening mammography
    • Hayes BD, Brodie C, O'Doherty A, et al: High-grade histologic features of DCIS are associated with R5 rather than R3 calcifications in breast screening mammography. Breast J 19:319-324, 2013
    • (2013) Breast J , vol.19 , pp. 319-324
    • Hayes, B.D.1    Brodie, C.2    O'Doherty, A.3
  • 18
    • 84880814807 scopus 로고    scopus 로고
    • Predictors of recurrence for ductal carcinoma in situ after breastconserving surgery
    • Benson JR, Wishart GC: Predictors of recurrence for ductal carcinoma in situ after breastconserving surgery. Lancet Oncol 14:348-357, 2013
    • (2013) Lancet Oncol , vol.14 , pp. 348-357
    • Benson, J.R.1    Wishart, G.C.2
  • 19
    • 84867040638 scopus 로고    scopus 로고
    • Tumour stage affects risk and prognosis of contralateral breast cancer: Results from a large Swedish population based study
    • Vichapat V, Garmo H, Holmqvist M, et al: Tumour stage affects risk and prognosis of contralateral breast cancer: Results from a large Swedish population based study. J Clin Oncol 30:3478-3485, 2012
    • (2012) J Clin Oncol , vol.30 , pp. 3478-3485
    • Vichapat, V.1    Garmo, H.2    Holmqvist, M.3
  • 20
    • 9444255722 scopus 로고    scopus 로고
    • Improving the quality of reporting of randomized controlled trials: The CONSORT statement
    • Begg C, Cho M, Eastwood S, et al: Improving the quality of reporting of randomized controlled trials: The CONSORT statement. JAMA 276:637-639, 1996
    • (1996) JAMA , vol.276 , pp. 637-639
    • Begg, C.1    Cho, M.2    Eastwood, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.